Abstract:The controllable construction of pure inorganic polyoxometalate (POM)zite materials with well-defined secondary building units (SBUs) is of great challenge. In this work, three distinct POM porous framework compounds 1–3 based on [MoVI36O112(H2O)16]8–({Mo36}) SBUs with various active growth points and transition-metal Ag linkers, both as countercations and structure directors, were self-assembled from simple salts to ordered porous frameworks (compound 1 is a 3D framework with channels of 20.1 Å in diameter, while compound 2 and compound 3 are 2D frameworks with channels of 29.1 and 26.8 Å in diameter, respectively, and the channels of compound 3 are formed by the fourfold spiral winding of {Mo36} SBUs) by controlling the reaction conditions, providing valuable experience for synthetic chemists to obtain more interesting and functional materials. The {Mo36}-based POM porous framework compounds 1–3 exhibit cell type-specific, dose-dependent, and pH-sensitive anticancer behavior, with the lowest IC50 in A549 lung cancer cells. Further, the monomer precursors AgNO3 and Mo36 SBU, however, are less cytotoxic to A549 cells than compound Ag–{Mo36}, suggesting a synergistic action of hybrid materials. Mechanistic insights into the anticancer activity of compounds 1–3 show that they induce mitochondria-mediated apoptosis and necrosis in A549 cells. Thus, {Mo36}-based POM porous framework materials with silver ions could serve as promising anticancer agents for lung cancer therapy.The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acs.chemmater.1c03837.Crystal data and structure refinement, bond valence sum analysis, some additional crystal structure graphs, Fourier transform infrared spectroscopy, powder XRD, TGA, XPS, EDS, elemental mapping, dye untake experiment, cytotoxicity assay, Annexin V/PI flow cytometry, and stability test (PDF)This article has not yet been cited by other publications.

Transition Metal Substituted Sandwich-Type Polyoxometalates with a Strong Metal–c (imidazole) Bond As Anticancer Agents

Discovery of a New Family of Polyoxometalate-Based Hybrids with Improved Catalytic Performances for Selective Sulfoxidation: the Synergy Between Classic Heptamolybdate Anions and Complex Cations.

Hetero-bimetallic Transition Metal-Substituted Krebs-type Polyoxometalate with N-chelating Ligand As Anticancer Agents

Ni/Mn-Complex-Tethered Tetranuclear Polyoxovanadates: Crystal Structure and Inhibitory Activity on Human Hepatocellular Carcinoma (HepG-2)

Synthesis and Investigations of the Antitumor Effects of First-Row Transition Metal(II) Complexes Supported by Two Fluorinated and Non-Fluorinated β-Diketonates

Polyoxometalate Modified by Zeolite Imidazole Framework for the Ph-Responsive Electrodynamic/Chemodynamic Therapy

Half-Sandwich Iridium(III), Rhodium(III), and Ruthenium(II) Complexes Chelating Hybrid sp 2 -N/sp 3 -N Donor Ligands to Achieve Improved Anticancer Selectivity

An Unprecedented Class of Benzoyldiazenido‐Functionalized Polyoxometalates with Enhanced Antitumour Activities

Aliphatic organoimido derivatives of polyoxometalates containing a bioactive ligand.

A New Class Of Functionalized Polyoxometalates: Synthesis, Structure And Preliminary Antitumor Activity Studies Of Three Arylimido Substituted Hexamolybdates Bearing A Strong Electron-Withdrawing Nitro Group, (Bu4n)(2)[Mo6o18( Nar)] (Ar=3-No2-C6h4, 2-Ch3-4-No2-C6h3, 2-Ch3-5-No2-C6h3)

Polyoxometalate-Based Organic-Inorganic Hybrids as Antitumor Drugs.

Triazole-based Mn(II), Fe(II), Ni(II), Cu(II) and Zn(II) complexes as potential anticancer agents – Physicochemical properties, in silico predictions and in vitro activity

Physico-Chemical Study of Mn(II), Co(II), Cu(II), Cr(III), and Pd(II) Complexes with Schiff-Base and Aminopyrimidyl Derivatives and Anti-Cancer, Antioxidant, Antimicrobial Applications

A Cu-Based Metal-Organic Framework Cu-Cip with Cuproptosis for Cancer Therapy and Inhibition of Cancer Cell Migration

Iminoamido chelated iridium(III) and ruthenium(II) anticancer complexes with mitochondria-targeting ability and potential to overcome cisplatin resistance

Controllable Assembly of Mo VI 36 -Based Polyoxometalate Porous Frameworks with Silver Ions and Lung Cancer Cell-Specific Cytotoxicity

Tris‐functionalized polyoxotungstovanadate‐mediated antitumor efficacy involves multiple cell death pathways

Progress in the Synthesis of Heteropolyoxometalate Clusters Andtheir Applications in Biological Treatment

Hydrothermal Synthesis and Characterization of POMs-based Compounds Based on Binuclear [M 2 (3-Bpo) 2 ] (M = Co, Cu) Unit and Its Derivatives

Increasing Anticancer Activity with Phosphine Ligation in Zwitterionic Half-Sandwich Iridium(III), Rhodium(III), and Ruthenium(II) Complexes

Exploiting Co(III)-Cyclopentadienyl Complexes To Develop Anticancer Agents